Related Experiment Videos
Improving the safety of transfusion therapy
1Memorial Blood Centers of Minnesota, Minneapolis, USA.
Clinics in Laboratory Medicine
|December 1, 1996
Summary
Significant progress has been made in reducing transfusion-transmitted diseases. Future safety enhancements may involve post-collection blood treatment and drug therapies to replace transfusions.
Area of Science:
- Transfusion Medicine
- Infectious Disease Prevention
Background:
- Substantial advancements have been achieved in minimizing the risk of transfusion-transmitted diseases.
- Current screening methods, while effective, incur significant costs and impact donor availability.
Purpose of the Study:
- To explore future strategies for enhancing blood transfusion safety.
- To identify cost-effective and resource-efficient approaches to disease prevention in transfusion medicine.
Main Methods:
- Literature review of current transfusion safety practices.
- Analysis of cost-benefit implications of additional screening tests.
- Exploration of emerging technologies and therapeutic agents.
Main Results:
- Current safety measures have considerably reduced transfusion-transmitted disease risks.
- Additional testing presents economic challenges and affects donor pool size.
- Post-collection pathogen reduction and pharmacologic alternatives show promise.
Conclusions:
- Future transfusion safety improvements likely depend on innovative post-collection treatments.
- Pharmacologic agents may offer a viable alternative to traditional blood transfusions, improving safety and resource management.